Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
Australia TGA 2020-21 Business Plan
Published Date: Dec 01, 2020Q and A about Therapeutic Goods Administration’s (TGA's) Business Plan for 2020-21 with John Skerritt, Deputy Secretary for Health Products Regulation in the Department of Health with responsibility for the TGA.
Author(s)
Richard O. Day
Professor of Clinical Pharmacology; University of New South Wales, Medicine
St. Vincent's Hospital
Professor Richard Day, AM (MBBS, FRACP, MD), is internationally recognized for his research, leadership, and advocacy in support of quality use of medicines. He has been deeply involved in Australia’s National Medicines Policy, culminating in his Chairmanship of the Pharmaceutical Health and Rational Use of Medicines Committee for the Federal Government (1999-2008), and is an active contributor to national resources such as the Australian Medicines Handbook and Therapeutic Guidelines. Professor Day has published over 500 peer-reviewed papers and been cited more than 21,000 times. He was the first non-US President of DIA, and his many awards include Member of the Order of Australia AM (2000) and the AMA Distinguished Service Award (2009).